A more comprehensive characterization using additional markers such as Pdgfra, Myh11, Pecam, and CD45 could provide deeper insights into the CAF subtypes derived from ASCs within the tumor microenvironment, which should be considered in future investigations. The gene discussed is MYH11; the disease is neoplasm.